LGALS3 and neoplasm: Injection of NOD-SCID mice with Gal-3-silenced human tumor cells or Gal-3-overexpressing human tumor cells, followed by intratumoral injection of human NK cells, resulted in a decrease or increase in tumor volume, respectively, compared with injection with untreated tumor cells.